Isoflavone Comprehensive Study by Type (Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others), Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others), Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)), Application (Nutraceutical, Pharmaceutical, Cosmetics, Animal Feed, Others), Form (Powder, Liquid) Players and Region - Global Market Outlook to 2030

Isoflavone Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.1%  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Isoflavone
Isoflavone is the group of compounds which consist of antioxidant properties. Isoflavone is primarily derived from carrots, peppers, tomatoes, broccoli, citrus fruits, berries, soybeans, and other fruits and also helps in vegetables. The global isoflavone market is driven by increasing consumer demand for nutraceuticals. The launch of different products in the cosmetics industry is projected to have a positive impact on the isoflavone market. Positive effect on blood vessels, lowering of blood pressure and prevention of inflammation in the body are some of the major factors which are projected to drive the growth of isoflavone market during the forecast period. They are used as sweetening and coloring agents in the food industry. Soy isoflavone is majorly found isoflavone across the globe which is used as an ingredient responsible for health functions in the form of soft drinks and capsules. It helps to maintain bone calcium.

AttributesDetails
Study Period2018-2030
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
CAGR5.1%


Competition among existing players is due to the Isoflavone market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Isoflavone Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage.The Vendors having a strong hold in the market are Cargill, ADM, BASF, Koninklijke DSM, and International Flavors & Fragrances. Analyst at AMA Research estimates that Asian Vendors will contribute the maximum growth to Global Isoflavone market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Cargill, Incorporated (United States), Archer Daniels Midland Company (ADM) (United States), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), International Flavors & Fragrances Inc. (Frutarom) (United States), Shanghai Freemen Americas LLC (United States), Nexira Inc. (France), Bio-gen Extracts Private Limited (India), Sikko Industries Ltd. (India), SK Bioland (South Korea), BioMax (India) and Avestia Pharma (India) are some of the key players that are part of study coverage. Additionally, the Vendors which are also part of the research coverage are NutraScience Labs (United States), Tradichem S.L. (Spain), Nutra Green Biotechnology (China), Herbo Nutra (India), FutureCeuticals Inc. (United States), Bio-gen Extracts (United States), Xena Bio Herbals Pvt. Ltd. (India), Sikko Industries (India), Biomax (India) and Lactonova (India).

Segmentation Overview
AMA Research has segmented the market of Global Isoflavone market by Type (Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others), Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others) and Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)), Application (Nutraceutical, Pharmaceutical, Cosmetics, Animal Feed and Others) and Region.



On the basis of geography, the market of Isoflavone has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Powder will boost the Isoflavone market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Occurrence of Health disorder such as Breast Cancer and Growing Demand for Longer Shelf Life

Market Growth Drivers:
Growing Demand for Functional Foods and High Adoption due to Increasing Health Consciousness among Consumer

Challenges:
Stringent Government Regulations Associated with Flavonoids, Rising Cost of Raw Materials and Fluctuation in Foreign Currency Exchange Rates While Transportation of Soybean

Restraints:
Lengthy Approval Process from Regional Regulatory Bodies, Due to Its Side Effects and High Certification Cost for Manufacturers

Opportunities:
High Investment in Chemical Sector by Healthcare Industry, Increasing Number of Online Sales Channels across the Globe, High Adoption due to Dietetic and Nutritional Supplement among the People and Huge Growth in Food and Beverages Industry

Market Leaders and their expansionary development strategies
In December 2021, Cargill has reached an agreement with Croda to acquire the majority of its performance technologies and industrial chemicals business on a cash-free, debt-free basis. The investment would dramatically expand Cargill’s bioindustrial footprint to better serve industrial manufacturers searching for “greener” ingredient solutions.
In 2021, Nua, a feminine hygiene company based in India, announced the launch of a new nutritional mix product called "Uplift". This nutritional drink consists of grape seed extract and soy isoflavones.
Sec. 101.82 Health claims: Soy protein and risk of coronary heart disease (CHD). (a) Relationship between diets that are low in saturated fat and cholesterol and that include soy protein and the risk of CHD. (1) Cardiovascular disease means diseases of the heart and circulatory system. CHD is one of the most common and serious forms of cardiovascular disease and refers to diseases of the heart muscle and supporting blood vessels. High blood total cholesterol and low density lipoprotein (LDL)-cholesterol levels are associated with increased risk of developing CHD. High CHD rates occur among people with high total cholesterol levels of 240 milligrams per deciliter (mg/dL) (6.21 millimole per liter (mmol/L)) or above and LDL-cholesterol levels of 160 mg/dL (4.13 mmol/L) or above. Borderline high risk total cholesterol levels range from 200 to 239 mg/dL (5.17 to 6.18 mmol/L) and 130 to 159 mg/dL (3.36 to 4.11 mmol/L) of LDL-cholesterol.

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Soy Isoflavones Manufacturers, Suppliers and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others)
  • Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others)
  • Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)
By Application
  • Nutraceutical
  • Pharmaceutical
  • Cosmetics
  • Animal Feed
  • Others
By Form
  • Powder
  • Liquid

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Functional Foods
      • 3.2.2. High Adoption due to Increasing Health Consciousness among Consumer
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations Associated with Flavonoids
      • 3.3.2. Rising Cost of Raw Materials
      • 3.3.3. Fluctuation in Foreign Currency Exchange Rates While Transportation of Soybean
    • 3.4. Market Trends
      • 3.4.1. Increasing Occurrence of Health disorder such as Breast Cancer
      • 3.4.2. Growing Demand for Longer Shelf Life
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Isoflavone, by Type, Application, Form and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Isoflavone (Value)
      • 5.2.1. Global Isoflavone by: Type (Value)
        • 5.2.1.1. Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 5.2.1.2. Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 5.2.1.3. Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)
      • 5.2.2. Global Isoflavone by: Application (Value)
        • 5.2.2.1. Nutraceutical
        • 5.2.2.2. Pharmaceutical
        • 5.2.2.3. Cosmetics
        • 5.2.2.4. Animal Feed
        • 5.2.2.5. Others
      • 5.2.3. Global Isoflavone by: Form (Value)
        • 5.2.3.1. Powder
        • 5.2.3.2. Liquid
      • 5.2.4. Global Isoflavone Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Isoflavone (Volume)
      • 5.3.1. Global Isoflavone by: Type (Volume)
        • 5.3.1.1. Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 5.3.1.2. Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 5.3.1.3. Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)
      • 5.3.2. Global Isoflavone by: Application (Volume)
        • 5.3.2.1. Nutraceutical
        • 5.3.2.2. Pharmaceutical
        • 5.3.2.3. Cosmetics
        • 5.3.2.4. Animal Feed
        • 5.3.2.5. Others
      • 5.3.3. Global Isoflavone by: Form (Volume)
        • 5.3.3.1. Powder
        • 5.3.3.2. Liquid
      • 5.3.4. Global Isoflavone Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Isoflavone (Price)
      • 5.4.1. Global Isoflavone by: Type (Price)
  • 6. Isoflavone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cargill, Incorporated (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Archer Daniels Midland Company (ADM) (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BASF SE (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Koninklijke DSM N.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. International Flavors & Fragrances Inc. (Frutarom) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Shanghai Freemen Americas LLC (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nexira Inc. (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-gen Extracts Private Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Sikko Industries Ltd. (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. SK Bioland (South Korea)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. BioMax (India)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Avestia Pharma (India)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Isoflavone Sale, by Type, Application, Form and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Isoflavone (Value)
      • 7.2.1. Global Isoflavone by: Type (Value)
        • 7.2.1.1. Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 7.2.1.2. Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 7.2.1.3. Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)
      • 7.2.2. Global Isoflavone by: Application (Value)
        • 7.2.2.1. Nutraceutical
        • 7.2.2.2. Pharmaceutical
        • 7.2.2.3. Cosmetics
        • 7.2.2.4. Animal Feed
        • 7.2.2.5. Others
      • 7.2.3. Global Isoflavone by: Form (Value)
        • 7.2.3.1. Powder
        • 7.2.3.2. Liquid
      • 7.2.4. Global Isoflavone Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Isoflavone (Volume)
      • 7.3.1. Global Isoflavone by: Type (Volume)
        • 7.3.1.1. Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 7.3.1.2. Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others)
        • 7.3.1.3. Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others)
      • 7.3.2. Global Isoflavone by: Application (Volume)
        • 7.3.2.1. Nutraceutical
        • 7.3.2.2. Pharmaceutical
        • 7.3.2.3. Cosmetics
        • 7.3.2.4. Animal Feed
        • 7.3.2.5. Others
      • 7.3.3. Global Isoflavone by: Form (Volume)
        • 7.3.3.1. Powder
        • 7.3.3.2. Liquid
      • 7.3.4. Global Isoflavone Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Isoflavone (Price)
      • 7.4.1. Global Isoflavone by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Isoflavone: by Type(USD Million)
  • Table 2. Isoflavone Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2018-2023)
  • Table 3. Isoflavone Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2018-2023)
  • Table 4. Isoflavone Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2018-2023)
  • Table 5. Isoflavone: by Application(USD Million)
  • Table 6. Isoflavone Nutraceutical , by Region USD Million (2018-2023)
  • Table 7. Isoflavone Pharmaceutical , by Region USD Million (2018-2023)
  • Table 8. Isoflavone Cosmetics , by Region USD Million (2018-2023)
  • Table 9. Isoflavone Animal Feed , by Region USD Million (2018-2023)
  • Table 10. Isoflavone Others , by Region USD Million (2018-2023)
  • Table 11. Isoflavone: by Form(USD Million)
  • Table 12. Isoflavone Powder , by Region USD Million (2018-2023)
  • Table 13. Isoflavone Liquid , by Region USD Million (2018-2023)
  • Table 14. South America Isoflavone, by Country USD Million (2018-2023)
  • Table 15. South America Isoflavone, by Type USD Million (2018-2023)
  • Table 16. South America Isoflavone, by Application USD Million (2018-2023)
  • Table 17. South America Isoflavone, by Form USD Million (2018-2023)
  • Table 18. Brazil Isoflavone, by Type USD Million (2018-2023)
  • Table 19. Brazil Isoflavone, by Application USD Million (2018-2023)
  • Table 20. Brazil Isoflavone, by Form USD Million (2018-2023)
  • Table 21. Argentina Isoflavone, by Type USD Million (2018-2023)
  • Table 22. Argentina Isoflavone, by Application USD Million (2018-2023)
  • Table 23. Argentina Isoflavone, by Form USD Million (2018-2023)
  • Table 24. Rest of South America Isoflavone, by Type USD Million (2018-2023)
  • Table 25. Rest of South America Isoflavone, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Isoflavone, by Form USD Million (2018-2023)
  • Table 27. Asia Pacific Isoflavone, by Country USD Million (2018-2023)
  • Table 28. Asia Pacific Isoflavone, by Type USD Million (2018-2023)
  • Table 29. Asia Pacific Isoflavone, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Isoflavone, by Form USD Million (2018-2023)
  • Table 31. China Isoflavone, by Type USD Million (2018-2023)
  • Table 32. China Isoflavone, by Application USD Million (2018-2023)
  • Table 33. China Isoflavone, by Form USD Million (2018-2023)
  • Table 34. Japan Isoflavone, by Type USD Million (2018-2023)
  • Table 35. Japan Isoflavone, by Application USD Million (2018-2023)
  • Table 36. Japan Isoflavone, by Form USD Million (2018-2023)
  • Table 37. India Isoflavone, by Type USD Million (2018-2023)
  • Table 38. India Isoflavone, by Application USD Million (2018-2023)
  • Table 39. India Isoflavone, by Form USD Million (2018-2023)
  • Table 40. South Korea Isoflavone, by Type USD Million (2018-2023)
  • Table 41. South Korea Isoflavone, by Application USD Million (2018-2023)
  • Table 42. South Korea Isoflavone, by Form USD Million (2018-2023)
  • Table 43. Taiwan Isoflavone, by Type USD Million (2018-2023)
  • Table 44. Taiwan Isoflavone, by Application USD Million (2018-2023)
  • Table 45. Taiwan Isoflavone, by Form USD Million (2018-2023)
  • Table 46. Australia Isoflavone, by Type USD Million (2018-2023)
  • Table 47. Australia Isoflavone, by Application USD Million (2018-2023)
  • Table 48. Australia Isoflavone, by Form USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Isoflavone, by Type USD Million (2018-2023)
  • Table 50. Rest of Asia-Pacific Isoflavone, by Application USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Isoflavone, by Form USD Million (2018-2023)
  • Table 52. Europe Isoflavone, by Country USD Million (2018-2023)
  • Table 53. Europe Isoflavone, by Type USD Million (2018-2023)
  • Table 54. Europe Isoflavone, by Application USD Million (2018-2023)
  • Table 55. Europe Isoflavone, by Form USD Million (2018-2023)
  • Table 56. Germany Isoflavone, by Type USD Million (2018-2023)
  • Table 57. Germany Isoflavone, by Application USD Million (2018-2023)
  • Table 58. Germany Isoflavone, by Form USD Million (2018-2023)
  • Table 59. France Isoflavone, by Type USD Million (2018-2023)
  • Table 60. France Isoflavone, by Application USD Million (2018-2023)
  • Table 61. France Isoflavone, by Form USD Million (2018-2023)
  • Table 62. Italy Isoflavone, by Type USD Million (2018-2023)
  • Table 63. Italy Isoflavone, by Application USD Million (2018-2023)
  • Table 64. Italy Isoflavone, by Form USD Million (2018-2023)
  • Table 65. United Kingdom Isoflavone, by Type USD Million (2018-2023)
  • Table 66. United Kingdom Isoflavone, by Application USD Million (2018-2023)
  • Table 67. United Kingdom Isoflavone, by Form USD Million (2018-2023)
  • Table 68. Netherlands Isoflavone, by Type USD Million (2018-2023)
  • Table 69. Netherlands Isoflavone, by Application USD Million (2018-2023)
  • Table 70. Netherlands Isoflavone, by Form USD Million (2018-2023)
  • Table 71. Rest of Europe Isoflavone, by Type USD Million (2018-2023)
  • Table 72. Rest of Europe Isoflavone, by Application USD Million (2018-2023)
  • Table 73. Rest of Europe Isoflavone, by Form USD Million (2018-2023)
  • Table 74. MEA Isoflavone, by Country USD Million (2018-2023)
  • Table 75. MEA Isoflavone, by Type USD Million (2018-2023)
  • Table 76. MEA Isoflavone, by Application USD Million (2018-2023)
  • Table 77. MEA Isoflavone, by Form USD Million (2018-2023)
  • Table 78. Middle East Isoflavone, by Type USD Million (2018-2023)
  • Table 79. Middle East Isoflavone, by Application USD Million (2018-2023)
  • Table 80. Middle East Isoflavone, by Form USD Million (2018-2023)
  • Table 81. Africa Isoflavone, by Type USD Million (2018-2023)
  • Table 82. Africa Isoflavone, by Application USD Million (2018-2023)
  • Table 83. Africa Isoflavone, by Form USD Million (2018-2023)
  • Table 84. North America Isoflavone, by Country USD Million (2018-2023)
  • Table 85. North America Isoflavone, by Type USD Million (2018-2023)
  • Table 86. North America Isoflavone, by Application USD Million (2018-2023)
  • Table 87. North America Isoflavone, by Form USD Million (2018-2023)
  • Table 88. United States Isoflavone, by Type USD Million (2018-2023)
  • Table 89. United States Isoflavone, by Application USD Million (2018-2023)
  • Table 90. United States Isoflavone, by Form USD Million (2018-2023)
  • Table 91. Canada Isoflavone, by Type USD Million (2018-2023)
  • Table 92. Canada Isoflavone, by Application USD Million (2018-2023)
  • Table 93. Canada Isoflavone, by Form USD Million (2018-2023)
  • Table 94. Mexico Isoflavone, by Type USD Million (2018-2023)
  • Table 95. Mexico Isoflavone, by Application USD Million (2018-2023)
  • Table 96. Mexico Isoflavone, by Form USD Million (2018-2023)
  • Table 97. Isoflavone Sales: by Type(K Tons)
  • Table 98. Isoflavone Sales Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2018-2023)
  • Table 99. Isoflavone Sales Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2018-2023)
  • Table 100. Isoflavone Sales Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2018-2023)
  • Table 101. Isoflavone Sales: by Application(K Tons)
  • Table 102. Isoflavone Sales Nutraceutical , by Region K Tons (2018-2023)
  • Table 103. Isoflavone Sales Pharmaceutical , by Region K Tons (2018-2023)
  • Table 104. Isoflavone Sales Cosmetics , by Region K Tons (2018-2023)
  • Table 105. Isoflavone Sales Animal Feed , by Region K Tons (2018-2023)
  • Table 106. Isoflavone Sales Others , by Region K Tons (2018-2023)
  • Table 107. Isoflavone Sales: by Form(K Tons)
  • Table 108. Isoflavone Sales Powder , by Region K Tons (2018-2023)
  • Table 109. Isoflavone Sales Liquid , by Region K Tons (2018-2023)
  • Table 110. South America Isoflavone Sales, by Country K Tons (2018-2023)
  • Table 111. South America Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 112. South America Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 113. South America Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 114. Brazil Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 115. Brazil Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 116. Brazil Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 117. Argentina Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 118. Argentina Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 119. Argentina Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 120. Rest of South America Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 121. Rest of South America Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 122. Rest of South America Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 123. Asia Pacific Isoflavone Sales, by Country K Tons (2018-2023)
  • Table 124. Asia Pacific Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 125. Asia Pacific Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 126. Asia Pacific Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 127. China Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 128. China Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 129. China Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 130. Japan Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 131. Japan Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 132. Japan Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 133. India Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 134. India Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 135. India Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 136. South Korea Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 137. South Korea Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 138. South Korea Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 139. Taiwan Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 140. Taiwan Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 141. Taiwan Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 142. Australia Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 143. Australia Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 144. Australia Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 145. Rest of Asia-Pacific Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 146. Rest of Asia-Pacific Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 147. Rest of Asia-Pacific Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 148. Europe Isoflavone Sales, by Country K Tons (2018-2023)
  • Table 149. Europe Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 150. Europe Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 151. Europe Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 152. Germany Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 153. Germany Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 154. Germany Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 155. France Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 156. France Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 157. France Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 158. Italy Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 159. Italy Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 160. Italy Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 161. United Kingdom Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 162. United Kingdom Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 163. United Kingdom Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 164. Netherlands Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 165. Netherlands Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 166. Netherlands Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 167. Rest of Europe Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 168. Rest of Europe Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 169. Rest of Europe Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 170. MEA Isoflavone Sales, by Country K Tons (2018-2023)
  • Table 171. MEA Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 172. MEA Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 173. MEA Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 174. Middle East Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 175. Middle East Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 176. Middle East Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 177. Africa Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 178. Africa Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 179. Africa Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 180. North America Isoflavone Sales, by Country K Tons (2018-2023)
  • Table 181. North America Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 182. North America Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 183. North America Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 184. United States Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 185. United States Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 186. United States Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 187. Canada Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 188. Canada Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 189. Canada Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 190. Mexico Isoflavone Sales, by Type K Tons (2018-2023)
  • Table 191. Mexico Isoflavone Sales, by Application K Tons (2018-2023)
  • Table 192. Mexico Isoflavone Sales, by Form K Tons (2018-2023)
  • Table 193. Isoflavone: by Type(USD/Units)
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Isoflavone: by Type(USD Million)
  • Table 207. Isoflavone Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2025-2030)
  • Table 208. Isoflavone Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2025-2030)
  • Table 209. Isoflavone Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region USD Million (2025-2030)
  • Table 210. Isoflavone: by Application(USD Million)
  • Table 211. Isoflavone Nutraceutical , by Region USD Million (2025-2030)
  • Table 212. Isoflavone Pharmaceutical , by Region USD Million (2025-2030)
  • Table 213. Isoflavone Cosmetics , by Region USD Million (2025-2030)
  • Table 214. Isoflavone Animal Feed , by Region USD Million (2025-2030)
  • Table 215. Isoflavone Others , by Region USD Million (2025-2030)
  • Table 216. Isoflavone: by Form(USD Million)
  • Table 217. Isoflavone Powder , by Region USD Million (2025-2030)
  • Table 218. Isoflavone Liquid , by Region USD Million (2025-2030)
  • Table 219. South America Isoflavone, by Country USD Million (2025-2030)
  • Table 220. South America Isoflavone, by Type USD Million (2025-2030)
  • Table 221. South America Isoflavone, by Application USD Million (2025-2030)
  • Table 222. South America Isoflavone, by Form USD Million (2025-2030)
  • Table 223. Brazil Isoflavone, by Type USD Million (2025-2030)
  • Table 224. Brazil Isoflavone, by Application USD Million (2025-2030)
  • Table 225. Brazil Isoflavone, by Form USD Million (2025-2030)
  • Table 226. Argentina Isoflavone, by Type USD Million (2025-2030)
  • Table 227. Argentina Isoflavone, by Application USD Million (2025-2030)
  • Table 228. Argentina Isoflavone, by Form USD Million (2025-2030)
  • Table 229. Rest of South America Isoflavone, by Type USD Million (2025-2030)
  • Table 230. Rest of South America Isoflavone, by Application USD Million (2025-2030)
  • Table 231. Rest of South America Isoflavone, by Form USD Million (2025-2030)
  • Table 232. Asia Pacific Isoflavone, by Country USD Million (2025-2030)
  • Table 233. Asia Pacific Isoflavone, by Type USD Million (2025-2030)
  • Table 234. Asia Pacific Isoflavone, by Application USD Million (2025-2030)
  • Table 235. Asia Pacific Isoflavone, by Form USD Million (2025-2030)
  • Table 236. China Isoflavone, by Type USD Million (2025-2030)
  • Table 237. China Isoflavone, by Application USD Million (2025-2030)
  • Table 238. China Isoflavone, by Form USD Million (2025-2030)
  • Table 239. Japan Isoflavone, by Type USD Million (2025-2030)
  • Table 240. Japan Isoflavone, by Application USD Million (2025-2030)
  • Table 241. Japan Isoflavone, by Form USD Million (2025-2030)
  • Table 242. India Isoflavone, by Type USD Million (2025-2030)
  • Table 243. India Isoflavone, by Application USD Million (2025-2030)
  • Table 244. India Isoflavone, by Form USD Million (2025-2030)
  • Table 245. South Korea Isoflavone, by Type USD Million (2025-2030)
  • Table 246. South Korea Isoflavone, by Application USD Million (2025-2030)
  • Table 247. South Korea Isoflavone, by Form USD Million (2025-2030)
  • Table 248. Taiwan Isoflavone, by Type USD Million (2025-2030)
  • Table 249. Taiwan Isoflavone, by Application USD Million (2025-2030)
  • Table 250. Taiwan Isoflavone, by Form USD Million (2025-2030)
  • Table 251. Australia Isoflavone, by Type USD Million (2025-2030)
  • Table 252. Australia Isoflavone, by Application USD Million (2025-2030)
  • Table 253. Australia Isoflavone, by Form USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Isoflavone, by Type USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Isoflavone, by Application USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Isoflavone, by Form USD Million (2025-2030)
  • Table 257. Europe Isoflavone, by Country USD Million (2025-2030)
  • Table 258. Europe Isoflavone, by Type USD Million (2025-2030)
  • Table 259. Europe Isoflavone, by Application USD Million (2025-2030)
  • Table 260. Europe Isoflavone, by Form USD Million (2025-2030)
  • Table 261. Germany Isoflavone, by Type USD Million (2025-2030)
  • Table 262. Germany Isoflavone, by Application USD Million (2025-2030)
  • Table 263. Germany Isoflavone, by Form USD Million (2025-2030)
  • Table 264. France Isoflavone, by Type USD Million (2025-2030)
  • Table 265. France Isoflavone, by Application USD Million (2025-2030)
  • Table 266. France Isoflavone, by Form USD Million (2025-2030)
  • Table 267. Italy Isoflavone, by Type USD Million (2025-2030)
  • Table 268. Italy Isoflavone, by Application USD Million (2025-2030)
  • Table 269. Italy Isoflavone, by Form USD Million (2025-2030)
  • Table 270. United Kingdom Isoflavone, by Type USD Million (2025-2030)
  • Table 271. United Kingdom Isoflavone, by Application USD Million (2025-2030)
  • Table 272. United Kingdom Isoflavone, by Form USD Million (2025-2030)
  • Table 273. Netherlands Isoflavone, by Type USD Million (2025-2030)
  • Table 274. Netherlands Isoflavone, by Application USD Million (2025-2030)
  • Table 275. Netherlands Isoflavone, by Form USD Million (2025-2030)
  • Table 276. Rest of Europe Isoflavone, by Type USD Million (2025-2030)
  • Table 277. Rest of Europe Isoflavone, by Application USD Million (2025-2030)
  • Table 278. Rest of Europe Isoflavone, by Form USD Million (2025-2030)
  • Table 279. MEA Isoflavone, by Country USD Million (2025-2030)
  • Table 280. MEA Isoflavone, by Type USD Million (2025-2030)
  • Table 281. MEA Isoflavone, by Application USD Million (2025-2030)
  • Table 282. MEA Isoflavone, by Form USD Million (2025-2030)
  • Table 283. Middle East Isoflavone, by Type USD Million (2025-2030)
  • Table 284. Middle East Isoflavone, by Application USD Million (2025-2030)
  • Table 285. Middle East Isoflavone, by Form USD Million (2025-2030)
  • Table 286. Africa Isoflavone, by Type USD Million (2025-2030)
  • Table 287. Africa Isoflavone, by Application USD Million (2025-2030)
  • Table 288. Africa Isoflavone, by Form USD Million (2025-2030)
  • Table 289. North America Isoflavone, by Country USD Million (2025-2030)
  • Table 290. North America Isoflavone, by Type USD Million (2025-2030)
  • Table 291. North America Isoflavone, by Application USD Million (2025-2030)
  • Table 292. North America Isoflavone, by Form USD Million (2025-2030)
  • Table 293. United States Isoflavone, by Type USD Million (2025-2030)
  • Table 294. United States Isoflavone, by Application USD Million (2025-2030)
  • Table 295. United States Isoflavone, by Form USD Million (2025-2030)
  • Table 296. Canada Isoflavone, by Type USD Million (2025-2030)
  • Table 297. Canada Isoflavone, by Application USD Million (2025-2030)
  • Table 298. Canada Isoflavone, by Form USD Million (2025-2030)
  • Table 299. Mexico Isoflavone, by Type USD Million (2025-2030)
  • Table 300. Mexico Isoflavone, by Application USD Million (2025-2030)
  • Table 301. Mexico Isoflavone, by Form USD Million (2025-2030)
  • Table 302. Isoflavone Sales: by Type(K Tons)
  • Table 303. Isoflavone Sales Soy (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2025-2030)
  • Table 304. Isoflavone Sales Chickpea (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2025-2030)
  • Table 305. Isoflavone Sales Red Clover (Food & Beverages, Nutraceuticals, Cosmetics, Others) , by Region K Tons (2025-2030)
  • Table 306. Isoflavone Sales: by Application(K Tons)
  • Table 307. Isoflavone Sales Nutraceutical , by Region K Tons (2025-2030)
  • Table 308. Isoflavone Sales Pharmaceutical , by Region K Tons (2025-2030)
  • Table 309. Isoflavone Sales Cosmetics , by Region K Tons (2025-2030)
  • Table 310. Isoflavone Sales Animal Feed , by Region K Tons (2025-2030)
  • Table 311. Isoflavone Sales Others , by Region K Tons (2025-2030)
  • Table 312. Isoflavone Sales: by Form(K Tons)
  • Table 313. Isoflavone Sales Powder , by Region K Tons (2025-2030)
  • Table 314. Isoflavone Sales Liquid , by Region K Tons (2025-2030)
  • Table 315. South America Isoflavone Sales, by Country K Tons (2025-2030)
  • Table 316. South America Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 317. South America Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 318. South America Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 319. Brazil Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 320. Brazil Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 321. Brazil Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 322. Argentina Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 323. Argentina Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 324. Argentina Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 325. Rest of South America Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 326. Rest of South America Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 327. Rest of South America Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 328. Asia Pacific Isoflavone Sales, by Country K Tons (2025-2030)
  • Table 329. Asia Pacific Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 330. Asia Pacific Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 331. Asia Pacific Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 332. China Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 333. China Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 334. China Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 335. Japan Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 336. Japan Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 337. Japan Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 338. India Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 339. India Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 340. India Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 341. South Korea Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 342. South Korea Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 343. South Korea Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 344. Taiwan Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 345. Taiwan Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 346. Taiwan Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 347. Australia Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 348. Australia Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 349. Australia Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 350. Rest of Asia-Pacific Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 351. Rest of Asia-Pacific Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 352. Rest of Asia-Pacific Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 353. Europe Isoflavone Sales, by Country K Tons (2025-2030)
  • Table 354. Europe Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 355. Europe Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 356. Europe Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 357. Germany Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 358. Germany Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 359. Germany Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 360. France Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 361. France Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 362. France Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 363. Italy Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 364. Italy Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 365. Italy Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 366. United Kingdom Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 367. United Kingdom Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 368. United Kingdom Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 369. Netherlands Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 370. Netherlands Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 371. Netherlands Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 372. Rest of Europe Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 373. Rest of Europe Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 374. Rest of Europe Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 375. MEA Isoflavone Sales, by Country K Tons (2025-2030)
  • Table 376. MEA Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 377. MEA Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 378. MEA Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 379. Middle East Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 380. Middle East Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 381. Middle East Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 382. Africa Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 383. Africa Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 384. Africa Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 385. North America Isoflavone Sales, by Country K Tons (2025-2030)
  • Table 386. North America Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 387. North America Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 388. North America Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 389. United States Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 390. United States Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 391. United States Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 392. Canada Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 393. Canada Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 394. Canada Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 395. Mexico Isoflavone Sales, by Type K Tons (2025-2030)
  • Table 396. Mexico Isoflavone Sales, by Application K Tons (2025-2030)
  • Table 397. Mexico Isoflavone Sales, by Form K Tons (2025-2030)
  • Table 398. Isoflavone: by Type(USD/Units)
  • Table 399. Research Programs/Design for This Report
  • Table 400. Key Data Information from Secondary Sources
  • Table 401. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Isoflavone: by Type USD Million (2018-2023)
  • Figure 5. Global Isoflavone: by Application USD Million (2018-2023)
  • Figure 6. Global Isoflavone: by Form USD Million (2018-2023)
  • Figure 7. South America Isoflavone Share (%), by Country
  • Figure 8. Asia Pacific Isoflavone Share (%), by Country
  • Figure 9. Europe Isoflavone Share (%), by Country
  • Figure 10. MEA Isoflavone Share (%), by Country
  • Figure 11. North America Isoflavone Share (%), by Country
  • Figure 12. Global Isoflavone: by Type K Tons (2018-2023)
  • Figure 13. Global Isoflavone: by Application K Tons (2018-2023)
  • Figure 14. Global Isoflavone: by Form K Tons (2018-2023)
  • Figure 15. South America Isoflavone Share (%), by Country
  • Figure 16. Asia Pacific Isoflavone Share (%), by Country
  • Figure 17. Europe Isoflavone Share (%), by Country
  • Figure 18. MEA Isoflavone Share (%), by Country
  • Figure 19. North America Isoflavone Share (%), by Country
  • Figure 20. Global Isoflavone: by Type USD/Units (2018-2023)
  • Figure 21. Global Isoflavone share by Players 2023 (%)
  • Figure 22. Global Isoflavone share by Players (Top 3) 2023(%)
  • Figure 23. Global Isoflavone share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Cargill, Incorporated (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cargill, Incorporated (United States) Revenue: by Geography 2023
  • Figure 27. Archer Daniels Midland Company (ADM) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Archer Daniels Midland Company (ADM) (United States) Revenue: by Geography 2023
  • Figure 29. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 30. BASF SE (Germany) Revenue: by Geography 2023
  • Figure 31. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 33. International Flavors & Fragrances Inc. (Frutarom) (United States) Revenue, Net Income and Gross profit
  • Figure 34. International Flavors & Fragrances Inc. (Frutarom) (United States) Revenue: by Geography 2023
  • Figure 35. Shanghai Freemen Americas LLC (United States) Revenue, Net Income and Gross profit
  • Figure 36. Shanghai Freemen Americas LLC (United States) Revenue: by Geography 2023
  • Figure 37. Nexira Inc. (France) Revenue, Net Income and Gross profit
  • Figure 38. Nexira Inc. (France) Revenue: by Geography 2023
  • Figure 39. Bio-gen Extracts Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 40. Bio-gen Extracts Private Limited (India) Revenue: by Geography 2023
  • Figure 41. Sikko Industries Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 42. Sikko Industries Ltd. (India) Revenue: by Geography 2023
  • Figure 43. SK Bioland (South Korea) Revenue, Net Income and Gross profit
  • Figure 44. SK Bioland (South Korea) Revenue: by Geography 2023
  • Figure 45. BioMax (India) Revenue, Net Income and Gross profit
  • Figure 46. BioMax (India) Revenue: by Geography 2023
  • Figure 47. Avestia Pharma (India) Revenue, Net Income and Gross profit
  • Figure 48. Avestia Pharma (India) Revenue: by Geography 2023
  • Figure 49. Global Isoflavone: by Type USD Million (2025-2030)
  • Figure 50. Global Isoflavone: by Application USD Million (2025-2030)
  • Figure 51. Global Isoflavone: by Form USD Million (2025-2030)
  • Figure 52. South America Isoflavone Share (%), by Country
  • Figure 53. Asia Pacific Isoflavone Share (%), by Country
  • Figure 54. Europe Isoflavone Share (%), by Country
  • Figure 55. MEA Isoflavone Share (%), by Country
  • Figure 56. North America Isoflavone Share (%), by Country
  • Figure 57. Global Isoflavone: by Type K Tons (2025-2030)
  • Figure 58. Global Isoflavone: by Application K Tons (2025-2030)
  • Figure 59. Global Isoflavone: by Form K Tons (2025-2030)
  • Figure 60. South America Isoflavone Share (%), by Country
  • Figure 61. Asia Pacific Isoflavone Share (%), by Country
  • Figure 62. Europe Isoflavone Share (%), by Country
  • Figure 63. MEA Isoflavone Share (%), by Country
  • Figure 64. North America Isoflavone Share (%), by Country
  • Figure 65. Global Isoflavone: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Cargill, Incorporated (United States)
  • Archer Daniels Midland Company (ADM) (United States)
  • BASF SE (Germany)
  • Koninklijke DSM N.V. (Netherlands)
  • International Flavors & Fragrances Inc. (Frutarom) (United States)
  • Shanghai Freemen Americas LLC (United States)
  • Nexira Inc. (France)
  • Bio-gen Extracts Private Limited (India)
  • Sikko Industries Ltd. (India)
  • SK Bioland (South Korea)
  • BioMax (India)
  • Avestia Pharma (India)
Additional players considered in the study are as follows:
NutraScience Labs (United States) , Tradichem S.L. (Spain) , Nutra Green Biotechnology (China) , Herbo Nutra (India) , FutureCeuticals Inc. (United States) , Bio-gen Extracts (United States) , Xena Bio Herbals Pvt. Ltd. (India) , Sikko Industries (India) , Biomax (India) , Lactonova (India)
Select User Access Type

Key Highlights of Report


Mar 2024 161 Pages 79 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Cargill, Incorporated (United States), Archer Daniels Midland Company (ADM) (United States), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), International Flavors & Fragrances Inc. (Frutarom) (United States), Shanghai Freemen Americas LLC (United States), Nexira Inc. (France), Bio-gen Extracts Private Limited (India), Sikko Industries Ltd. (India), SK Bioland (South Korea), BioMax (India) and Avestia Pharma (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Occurrence of Health disorder such as Breast Cancer " is seen as one of major influencing trends for Isoflavone Market during projected period 2023-2030.
The Isoflavone market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Isoflavone Market Report?